Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Radiation with or without Induction Chemotherapy in Stage III NSCLC
NCT00003202Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 1998
- Primary completion
- Apr 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in non-small cell lung cancer (NSCLC), sponsored by Wake Forest University Health Sciences. Started Jan 1998; status: completed.
02
Drugs
gemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00003202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003202.